News

Prescriptions for Eli Lilly’s new weight-loss drug get off to a strong start and confirm bright outlook

  •  

Eli Lilly’s office in La Jolla, California.

Konrad Fiedler | Bloomberg | Getty Images

The launch of Eli Lilly‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday.


This article was originally published on CNBC